Catheter Precision Q2 revenue $93K, net loss $4.2M; cash only $16K at June 30

Catheter Precision, Inc.

Q2 revenue $93K, H1 $175K; net loss Q2 $4.2M, H1 $6.9M.
Cash at June 30 just $16K; rose to $330K by Aug 12 but remains extremely low.
First commercial LockeT sales in US: $38K in both Q2 and H1; 23 hospitals scheduling evaluations.
Total assets $26M, shareholders' equity $14.3M as of June 30.
14 new sales/clinical hires; VIVO evaluation started in Italy; VIVO EU Registry completed in June.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.